Clinical Trial Update: Citicoline as Neuroprotector in Preterm [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating citicoline as a neuroprotective treatment for preterm infants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Neuroprotection
• Preterm Birth Complications

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Pre-Term | Phase 3 | Status: RECRUITING